Funds and ETFs Novonesis A/S

Equities

NSIS B

DK0060336014

Specialty Chemicals

Market Closed - Nasdaq Copenhagen 08:29:39 26/04/2024 pm IST 5-day change 1st Jan Change
389.6 DKK +1.27% Intraday chart for Novonesis A/S +0.67% +4.99%

ETFs positioned on Novonesis A/S

Name Weight AuM 1st Jan change Investor Rating
1.80% 192 M€ +13.43%
0.50% 18 M€ +3.79% -
0.20% 88 M€ +10.37% -
0.14% 6 M€ -.--% -
0.11% 4 M€ -.--% -
0.11% 6 M€ -.--%
0.10% 182 M€ +6.98%
0.10% 3,859 M€ +18.82% -
0.10% 469 M€ -2.05% -
0.07% 1,120 M€ +0.40%
0.05% 23 M€ -.--% -
0.05% 786 M€ -.--%
0.05% 206 M€ -.--%
0.05% 10 M€ -3.35% -
0.05% 267 M€ +5.99%
0.05% 276 M€ +11.40% -
0.05% 277 M€ -.--% -
0.05% 194 M€ +7.48% -
0.05% 441 M€ +10.26%
0.04% 284 M€ -.--%
0.03% 0 M€ 0.00% -
0.03% 273 M€ +15.83%
0.02% 205 M€ -.--%
0.02% 34 M€ +6.71% -
0.02% 7 M€ +0.11% -
0.02% 1,166 M€ +0.26% -
0.02% 607 M€ +0.05% -
0.01% 389 M€ +6.83% -
Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
389.6 DKK
Average target price
430.9 DKK
Spread / Average Target
+10.59%
Consensus
  1. Stock Market
  2. Equities
  3. NSIS B Stock
  4. Funds and ETFs Novonesis A/S